Cargando…

Oligodendroglial alpha-synucleinopathy and MSA-like cardiovascular autonomic failure: Experimental evidence

Multiple system atrophy (MSA) is a fatal, rapidly progressive neurodegenerative disease with limited symptomatic treatment options. Discrimination of MSA from other degenerative disorders crucially depends on the presence of early and severe cardiovascular autonomic failure (CAF). We have previously...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kuzdas, Daniela, Stemberger, Sylvia, Gaburro, Stefano, Stefanova, Nadia, Singewald, Nicolas, Wenning, Gregor K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academic Press 2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3748345/ https://www.ncbi.nlm.nih.gov/pubmed/23399889 http://dx.doi.org/10.1016/j.expneurol.2013.02.002

Ejemplares similares

Targeted overexpression of human α-synuclein in oligodendroglia induces lesions linked to MSA -like progressive autonomic failure
por: Stemberger, Sylvia, et al.
Publicado: (2010)

The role of cardiovascular autonomic failure in the differential diagnosis of α-synucleinopathies
por: Leys, Fabian, et al.
Publicado: (2021)

The Role of Glia in Alpha-Synucleinopathies
por: Fellner, Lisa, et al.
Publicado: (2012)

Neuroinflammation and Glial Phenotypic Changes in Alpha-Synucleinopathies
por: Refolo, Violetta, et al.
Publicado: (2019)

Early autonomic and cognitive dysfunction in PD, DLB and MSA: blurring the boundaries between α-synucleinopathies
por: Palermo, Giovanni, et al.
Publicado: (2020)

Pure Autonomic Failure-A Localized Alpha Synucleinopathy with a Potential for Conversion to More Extensive Alpha Synucleinopathies
por: Bhattacharjee, Shakya, et al.
Publicado: (2022)

Limited effects of dysfunctional macroautophagy on the accumulation of extracellularly derived α-synuclein in oligodendroglia: implications for MSA pathogenesis
por: Fellner, Lisa, et al.
Publicado: (2018)

High-salt diet does not boost neuroinflammation and neurodegeneration in a model of α-synucleinopathy
por: Heras-Garvin, Antonio, et al.
Publicado: (2020)

Oligodendroglial α‐synucleinopathy‐driven neuroinflammation in multiple system atrophy
por: Hoffmann, Alana, et al.
Publicado: (2019)

Signs of Chronic Hypoxia Suggest a Novel Pathophysiological Event in α‐Synucleinopathies
por: Heras‐Garvin, Antonio, et al.
Publicado: (2020)

Mesenchymal Stem Cells in a Transgenic Mouse Model of Multiple System Atrophy: Immunomodulation and Neuroprotection
por: Stemberger, Sylvia, et al.
Publicado: (2011)

Multiple system atrophy as emerging template for accelerated drug discovery in α-synucleinopathies
por: Krismer, Florian, et al.
Publicado: (2014)

Toll-like receptor 4 stimulation with monophosphoryl lipid A ameliorates motor deficits and nigral neurodegeneration triggered by extraneuronal α-synucleinopathy
por: Venezia, Serena, et al.
Publicado: (2017)

Region-Specific Effects of Immunotherapy With Antibodies Targeting α-synuclein in a Transgenic Model of Synucleinopathy
por: Kallab, Martin, et al.
Publicado: (2018)

Anle138b Partly Ameliorates Motor Deficits Despite Failure of Neuroprotection in a Model of Advanced Multiple System Atrophy
por: Fellner, Lisa, et al.
Publicado: (2016)

Histone Deacetylase 6 and the Disease Mechanisms of α-Synucleinopathies
por: Lemos, Miguel, et al.
Publicado: (2020)

Autonomic Dysfunction in α-Synucleinopathies
por: Mendoza-Velásquez, José Javier, et al.
Publicado: (2019)

TNFα inhibitors as targets for protective therapies in MSA: a viewpoint
por: Ndayisaba, Alain, et al.
Publicado: (2019)

Towards translational therapies for multiple system atrophy
por: Kuzdas-Wood, Daniela, et al.
Publicado: (2014)

Overexpression of α-synuclein in oligodendrocytes does not increase susceptibility to focal striatal excitotoxicity
por: Kuzdas-Wood, Daniela, et al.
Publicado: (2015)

Autonomic ganglionic injection of α-synuclein fibrils as a model of pure autonomic failure α-synucleinopathy
por: Wang, Xue-Jing, et al.
Publicado: (2020)

Calcium: Alpha-Synuclein Interactions in Alpha-Synucleinopathies
por: Rcom-H'cheo-Gauthier, Alexandre N., et al.
Publicado: (2016)

Metallothionein, Copper and Alpha-Synuclein in Alpha-Synucleinopathies
por: Okita, Yuho, et al.
Publicado: (2017)

Cardiac Alpha-Synuclein Is Present in Alpha-Synucleinopathies
por: Javanshiri, Keivan, et al.
Publicado: (2022)

Alpha-synuclein mRNA expression in oligodendrocytes in MSA
por: Asi, Yasmine T, et al.
Publicado: (2014)

Suppression of dynamin GTPase decreases α-synuclein uptake by neuronal and oligodendroglial cells: a potent therapeutic target for synucleinopathy
por: Konno, Masatoshi, et al.
Publicado: (2012)

A comparison of MSA tools
por: Essoussi, Nadia, et al.
Publicado: (2008)

Altered sleep and neurovascular dysfunction in alpha-synucleinopathies: the perfect storm for glymphatic failure
por: Buongiorno, Mariateresa, et al.
Publicado: (2023)

Chronic treatment with a selective neurokinin-1 receptor antagonist in a mouse model of trait anxiety and depression: focus on behaviour and neuropeptidergic mechanisms
por: Sartori, Simone B, et al.
Publicado: (2008)

Genetic Diversity of Babesia bovis MSA-1, MSA-2b and MSA-2c in China
por: Wang, Jinming, et al.
Publicado: (2020)

Animal models of multiple system atrophy
por: Stefanova, Nadia, et al.
Publicado: (2015)

Gene Therapy to Modulate Alpha-Synuclein in Synucleinopathies
por: Sandoval, Ivette M., et al.
Publicado: (2021)

Involvement of Peripheral Nerves in the Transgenic PLP-α-Syn Model of Multiple System Atrophy: Extending the Phenotype
por: Kuzdas-Wood, Daniela, et al.
Publicado: (2015)

Parkinsonian and Cerebellar Phenotypes of Probable MSA: An Insight in to Prognostic Factors Based on Autonomic Functions
por: Rukmani, Malligurki Raghurama, et al.
Publicado: (2020)

MSA Mimic? Rare Occurrence of Anti-Hu Autonomic Failure and Thymoma in a Patient with Parkinsonism: Case Report and Literature Review
por: Ricigliano, Vito A. G., et al.
Publicado: (2018)

Alpha‐synuclein RT‐QuIC in the CSF of patients with alpha‐synucleinopathies
por: Fairfoul, Graham, et al.
Publicado: (2016)

Alpha-Synuclein in Skin Nerve Fibers as a Biomarker for Alpha-Synucleinopathies
por: Kim, Jee Young, et al.
Publicado: (2019)

Linking the Endoplasmic Reticulum to Parkinson’s Disease and Alpha-Synucleinopathy
por: Colla, Emanuela
Publicado: (2019)

Plant poisoning leads to alpha-synucleinopathy and neuromelanopathy in kangaroos
por: Tayebi, Mourad, et al.
Publicado: (2019)

Alpha-Synuclein: Mechanisms of Release and Pathology Progression in Synucleinopathies
por: Brás, Inês C., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_31mq0cf30q1g2u4eds440pvois